Back to CYTK
STATE STREET CORP CYTK Position History
Cytokinetics, Incorporated • Healthcare
Quarters held
22
Latest value
$553.2M
Q2 2026
Peak value
$553.2M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $492M |
| Q4 2023 | $20.2M |
| Q1 2024 | $316.9M |
| Q1 2024 | $18.7M |
| Q2 2024 | $354.8M |
| Q2 2024 | $14.1M |
| Q3 2024 | $341M |
| Q3 2024 | $14.6M |
| Q4 2024 | $290.1M |
| Q4 2024 | $14.5M |
| Q1 2025 | $244.6M |
| Q1 2025 | $12.9M |
| Q2 2025 | $210.6M |
| Q2 2025 | $10.7M |
| Q3 2025 | $308.7M |
| Q4 2025 | $370.1M |
| Q1 2026 | $18M |
| Q1 2026 | $378.7M |
| Q2 2026 | $11.4M |
| Q2 2026 | $553.2M |
| Q2 2026 | $11.4M |
| Q2 2026 | $553.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $553.2M | 6.49M | — | — |
| Q2 2026 | $11.4M | 2.57M | — | — |
| Q2 2026 | $553.2M | 6.49M | — | — |
| Q2 2026 | $11.4M | 2.57M | — | — |
| Q1 2026 | $378.7M | 5.75M | — | — |
| Q1 2026 | $18M | 4.12M | — | — |
| Q4 2025 | $370.1M | 5.83M | — | — |
| Q3 2025 | $308.7M | 5.62M | — | — |
| Q2 2025 | $10.7M | 9.94M | — | — |
| Q2 2025 | $210.6M | 6.37M | — | — |
| Q1 2025 | $12.9M | 11.19M | — | — |
| Q1 2025 | $244.6M | 6.09M | — | — |
| Q4 2024 | $14.5M | 11.94M | — | — |
| Q4 2024 | $290.1M | 6.17M | — | — |
| Q3 2024 | $14.6M | 11.24M | — | — |
| Q3 2024 | $341M | 6.46M | — | — |
| Q2 2024 | $14.1M | 10.64M | — | — |
| Q2 2024 | $354.8M | 6.55M | — | — |
| Q1 2024 | $18.7M | 11.74M | — | — |
| Q1 2024 | $316.9M | 4.52M | — | — |
| Q4 2023 | $20.2M | 11.34M | — | — |
| Q4 2023 | $492M | 5.89M | — | — |
Other funds holding CYTK
$704.4M
$601.9M
$555.8M
$467.5M
$388.6M
$251.7M